PRTA Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
620.0K
-38.6%
1.0M
-98.0%
51.1M
+243157.1%
21.0K
-99.1%
2.4M
Cost of Revenue
0
0
0
0
0
Gross Profit
620.0K
-38.6%
1.0M
-98.0%
51.1M
+243157.1%
21.0K
-99.1%
2.4M
Operating Expenses
19.4M
-12.1%
22.1M
+5.0%
21.0M
-13.1%
24.2M
-43.2%
42.7M
R&D
8.4M
-4.2%
8.8M
-30.3%
12.6M
-13.4%
14.6M
-49.6%
28.9M
SG&A
10.6M
-2.8%
10.9M
-14.0%
12.7M
+0.2%
12.6M
-4.5%
13.2M
Operating Income
-18821000
+10.8%
-21101000
-170.3%
30.0M
+224.1%
-24203000
+39.9%
-40240000
EBITDA
-18192000
+1.6%
-18490000
-171.2%
26.0M
+196.2%
-26993000
+31.7%
-39532000
Net Income
-16509000
+11.2%
-18583000
-156.8%
32.7M
+251.6%
-21589000
+40.9%
-36541000
EPS (Basic)
$-0.32
+11.1%
$-0.36
-159.0%
$0.61
+252.5%
$-0.40
+41.2%
$-0.68
EPS (Diluted)
$-0.32
+11.1%
$-0.36
-160.0%
$0.60
+250.0%
$-0.40
+41.2%
$-0.68
Shares (Diluted)
51.4M
-1.4%
52.1M
-3.6%
54.1M
+0.5%
53.8M
+0.0%
53.8M
Prothena (PRTA) — Financials